<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Tummler, B.</title>
    <link>http://repub.eur.nl/res/aut/3765/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings (Article)</title>
      <link>http://repub.eur.nl/res/pub/8415/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>To investigate the impact of chloride (Cl(-)) permeability, mediated by
      residual activity of the cystic fibrosis transmembrane conductance
      regulator (CFTR) or by other Cl(-) channels, on the manifestations of
      cystic fibrosis (CF), we determined Cl(-) transport properties of the
      respiratory and intestinal tracts in Delta F508 homozygous twins and
      siblings. In the majority of patients, cAMP and/or Ca(2+)-regulated Cl(-)
      conductance was detected in the airways and intestine. Our finding of
      cAMP-mediated Cl(-) conductance suggests that, in vivo, at least some
      Delta F508 CFTR can reach the plasma membrane and affect Cl(-)
      permeability. In respiratory tissue, the expression of basal CFTR-mediated
      Cl(-) conductance, demonstrated by 30% of Delta F508 homozygotes, was
      identified as a positive predictor of milder CF disease. In intestinal
      tissue, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid-insensitive
      (DIDS-insensitive) Cl(-) secretion, which is indicative of functional CFTR
      channels, correlated with a milder phenotype, whereas DIDS-sensitive Cl(-)
      secretion was observed mainly in more severely affected patients. The more
      concordant Cl(-) secretory patterns within monozygous twins compared with
      dizygous pairs imply that genes other than CFTR significantly influence
      the manifestation of the basic defect.</description>
    </item> <item>
      <title>Clinical presentation of exclusive cystic fibrosis lung disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/9096/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>The diagnosis of cystic fibrosis (CF) is based on the occurrence of two
          mutations in the cystic fibrosis transmembrane conductance regulator
          (CFTR) gene and on assays that measure the basic defect of abnormal
          chloride transport in the affected organs. However, in cases of atypical
          CF not all diagnostic tests may be positive. We present a patient with an
          atypical CF phenotype in whom the only presenting symptom was severe
          CF-like lung disease substantiated by an abnormal nasal potential
          difference. Genetic analysis showed that the patient was a symptomatic
          heterozygote, which suggests that one lesion in the CFTR gene may be
          sufficient to cause CF-like lung disease.</description>
    </item> <item>
      <title>Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods (Article)</title>
      <link>http://repub.eur.nl/res/pub/9116/</link>
      <pubDate>1999-01-01T00:00:00Z</pubDate>
      <description>Cystic fibrosis (CF) predisposes patients to bacterial colonization and
          infection of the lower airways. Several species belonging to the genus
          Burkholderia are potential CF-related pathogens, but microbiological
          identification may be complicated. This situation is not in the least due
          to the poorly defined taxonomic status of these bacteria, and further
          validation of the available diagnostic assays is required. A total of 114
          geographically diverse bacterial isolates, previously identified in
          reference laboratories as Burkholderia cepacia (n = 51), B. gladioli (n =
          14), Ralstonia pickettii (n = 6), B. multivorans (n = 2), Stenotrophomonas
          maltophilia (n = 3), and Pseudomonas aeruginosa (n = 11), were collected
          from environmental, clinical, and reference sources. In addition, 27
          clinical isolates putatively identified as Burkholderia spp. were
          recovered from the sputum of Dutch CF patients. All isolates were used to
          evaluate the accuracy of two selective growth media, four systems for
          biochemical identification (API 20NE, Vitek GNI, Vitek NFC, and
          MicroScan), and three different PCR-based assays. The PCR assays amplify
          different parts of the ribosomal DNA operon, either alone or in
          combination with cleavage by various restriction enzymes (PCR-restriction
          fragment length polymorphism [RFLP] analysis). The best system for the
          biochemical identification of B. cepacia appeared to be the API 20NE test.
          None of the biochemical assays successfully grouped the B. gladioli
          strains. The PCR-RFLP method appeared to be the optimal method for
          accurate nucleic acid-mediated identification of the different
          Burkholderia spp. With this method, B. gladioli was also reliably
          classified in a separate group. For the laboratory diagnosis of B.
          cepacia, we recommend parallel cultures on blood agar medium and selective
          agar plates. Further identification of colonies with a Burkholderia
          phenotype should be performed with the API 20NE test. For final
          confirmation of species identities, PCR amplification of the small-subunit
          rRNA gene followed by RFLP analysis with various enzymes is recommended.</description>
    </item>
  </channel>
</rss>